Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$25.34 - $34.28 $22.8 Million - $30.8 Million
898,886 New
898,886 $28.9 Million
Q2 2023

Aug 14, 2023

SELL
$25.15 - $32.86 $5.4 Million - $7.05 Million
-214,552 Reduced 28.44%
539,877 $17.5 Million
Q1 2023

May 15, 2023

SELL
$17.5 - $25.9 $3.29 Million - $4.87 Million
-188,127 Reduced 19.96%
754,429 $19.5 Million
Q4 2022

Feb 14, 2023

SELL
$13.95 - $19.28 $15.4 Million - $21.3 Million
-1,107,110 Reduced 54.01%
942,556 $16.9 Million
Q3 2022

Nov 14, 2022

BUY
$14.66 - $18.3 $9.9 Million - $12.4 Million
675,215 Added 49.13%
2,049,666 $34.7 Million
Q2 2022

Aug 15, 2022

BUY
$14.1 - $20.26 $19.4 Million - $27.8 Million
1,374,451 New
1,374,451 $21.7 Million

Others Institutions Holding STVN

About Stevanato Group S.p.A.


  • Ticker STVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 264,700,000
  • Market Cap $5.65B
  • Description
  • Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...
More about STVN
Track This Portfolio

Track Arrow Mark Colorado Holdings LLC Portfolio

Follow Arrow Mark Colorado Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.